How big is Danaher Corp.?

As of Jun 18, Danaher Corp. has a market capitalization of $167.63 billion, with recent net sales of $23.82 billion and a net profit of $3.77 billion.

Market Cap: As of Jun 18, Danaher Corp. has a market capitalization of 167,634.35 million, classifying it as a Large Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Danaher Corp. reported net sales of 23,820.00 million and a net profit of 3,765.00 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 49,543.00 million and total assets of 77,542.00 million.

What does Danaher Corp. do?

Danaher Corporation designs and manufactures products and services in the Pharmaceuticals & Biotechnology industry, with recent net sales of $5.74 billion and a market cap of approximately $167.63 billion. Key metrics include a P/E ratio of 40.00 and a dividend yield of 0.49%.

Overview:<BR>Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services in the Pharmaceuticals & Biotechnology industry, with a market capitalization in the large-cap bracket.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 5,741 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 954 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 167,634.35 Million (Large Cap)<BR><BR>Key Metrics:<BR>P/E: 40.00 <BR>Dividend Yield: 0.49% <BR>Debt Equity: 0.31 <BR>Return on Equity: 8.34% <BR>Price to Book: 3.30 <BR><BR>Contact Details:<BR>Address: 2200 Pennsylvania Ave NW Ste 800w, WASHINGTON DC: 20037-1731 <BR>Tel: 1 202 8280850 <BR>Fax: 1 202 8280860 <BR>Website: https://www.danaher.com/

Should I buy, sell or hold Danaher Corp.?

Who are in the management team of Danaher Corp.?

As of March 2022, the management team of Danaher Corp. includes Steven Rales (Chairman), Rainer Blair (CEO), Linda Hefner Filler (Lead Independent Director), Mitchell Rales, Teri List-Stoll, Walter Lohr, and Jessica Mega (all Independent Directors).

As of March 2022, the management team of Danaher Corp. includes the following individuals:<BR><BR>- Mr. Steven Rales, Chairman of the Board<BR>- Mr. Rainer Blair, President, Chief Executive Officer, Director<BR>- Ms. Linda Hefner Filler, Lead Independent Director<BR>- Mr. Mitchell Rales, Director<BR>- Ms. Teri List-Stoll, Independent Director<BR>- Mr. Walter Lohr, Independent Director<BR>- Dr. Jessica Mega, Independent Director

Is Danaher Corp. overvalued or undervalued?

As of October 17, 2025, Danaher Corp. is considered very expensive with a P/E ratio of 40 and has underperformed the S&P 500, showing a year-to-date return of -8.93% compared to the index's 13.30%.

As of 17 October 2025, the valuation grade for Danaher Corp. has moved from expensive to very expensive, indicating a significant concern regarding its current valuation. The company is overvalued based on its key metrics, which include a P/E ratio of 40, a Price to Book Value of 3.30, and an EV to EBITDA of 24.40. In comparison, Abbott Laboratories, which is considered fairly valued, has a P/E ratio of 18.36, while Thermo Fisher Scientific, also fairly valued, has a P/E ratio of 30.06.<BR><BR>The stock has underperformed against the S&P 500, with a year-to-date return of -8.93% compared to the S&P 500's 13.30%, and a one-year return of -23.13% versus the S&P 500's 14.08%. This trend reinforces the notion that Danaher Corp. is not only overvalued but also struggling to deliver returns relative to the broader market.

Is Danaher Corp. technically bullish or bearish?

As of October 31, 2025, Danaher Corp. shows a mildly bullish technical trend with positive momentum indicators, but it has underperformed the S&P 500 significantly, warranting cautious consideration.

As of 31 October 2025, the technical trend for Danaher Corp. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating positive momentum. The daily moving averages are also bullish, supporting the upward trend. However, the monthly Bollinger Bands are bearish, which suggests some caution. The KST shows a bullish stance on the weekly timeframe but is bearish monthly, indicating mixed signals. Overall, the Dow Theory indicates a mildly bullish trend on the weekly basis with no trend monthly.<BR><BR>In terms of performance, Danaher has underperformed the S&P 500 across multiple periods, with a year-to-date return of -6.85% compared to the S&P 500's 16.30%, and a one-year return of -13.69% versus 19.89% for the benchmark. This underperformance highlights the need for careful consideration despite the current mildly bullish technical stance.